Is AMPX a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Amprius Technologies (AMPX) rests on Energy-density edge: Amprius's core pitch is that silicon-anode cells store more energy per unit of weight and volume than conventional lithium-ion. The bear case rests on amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. Analysts covering it publish targets from $14.00 to $30.00 against a $7.71 price, so even the professionals disagree by 72% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Amprius Technologies develops and sells silicon-anode lithium-ion batteries that target higher energy density than conventional graphite-anode cells, meaning more energy in the same weight and volume. Its SiMaxx platform uses a proprietary 100% silicon-nanowire anode made in-house at its Fremont, California facility and is positioned for the most demanding high-performance uses, while its newer SiCore platform is a commercially available silicon-anode line, including a 450 Wh/kg cell, designed for near-term mass production. Higher energy density matters most where weight is critical, which is why Amprius concentrates on aviation, electric vertical takeoff and landing (eVTOL) aircraft, drones, defense, and electric vehicles. The company ships cells to a broad and growing base of customers and holds defense agreements such as a contract with the U.S. Defense Innovation Unit for NDAA-compliant advanced drone batteries. Amprius was founded out of silicon-anode research and went public in 2022 through a SPAC merger, trading on the New York Stock Exchange under the ticker AMPX. The company is in an early commercial ramp: revenue has grown quickly off a small base, but it remains unprofitable. A notable strategic shift came in January 2026, when Amprius terminated a 15-year lease for a planned Brighton, Colorado manufacturing facility for roughly $20 million, eliminating an obligation it valued at over $110 million, and moved toward a capital-light model that uses external contract manufacturers (including a Korea-based alliance) to add capacity with less fixed investment. The company continues to operate and expand pilot and production lines at Fremont while routing volume scale-up through partners. The ramp has continued through 2026. Revenue reached about $34.0 million in the second quarter, up about 126% from a year earlier, and trailing-twelve-month revenue is about $109 million, with a quarterly net loss near $5 million. In late September Amprius announced a grant of up to $75 million to support US production of high-energy-density batteries for unmanned aerial systems, and in early October it signed a contract manufacturing agreement with Caminus for US pouch cell production of drone batteries. It also filed a shelf registration in October, which allows it to sell securities later.
The bull case: what would have to be true for $30.00
The most optimistic published target on AMPX is $30.00, +289.1% from the $7.71 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
Energy-density edge.
Amprius's core pitch is that silicon-anode cells store more energy per unit of weight and volume than conventional lithium-ion. In weight-sensitive uses such as drones, eVTOL, and aviation, that can translate into longer flight time or range, which is the central reason customers and investors track the company. SiCore is positioned as a commercially available, scalable line, and SiMaxx targets the highest-performance niche.
Aviation, defense, and drone demand.
The company has concentrated revenue in drones and aviation and holds defense agreements, including an expanded contract with the U.S. Defense Innovation Unit covering multiple cylindrical and pouch cell formats. Defense and aviation buyers value energy density and domestic, NDAA-compliant supply, which gives Amprius a differentiated wedge versus commodity lithium-ion suppliers. In September 2026 the company secured a grant of up to $75 million for American high-energy-density battery production aimed at unmanned aerial systems, and the stock rose about 11% on the news.
Capital-light manufacturing scale-up.
After canceling its planned Brighton, Colorado factory, Amprius shifted to a contract-manufacturing model, signing partnerships (including a Korea-based alliance) to secure hundreds of MWh of SiCore capacity with limited capital spending. The aim is to add production quickly while preserving cash, though it makes the company dependent on partners for quality, timing, and cost. The model gained a domestic leg in October 2026, when Caminus signed a contract manufacturing agreement to produce Amprius pouch cells for drone batteries in the US.
Early-commercial revenue ramp.
Revenue has been growing rapidly off a small base: about $28.5 million in Q1 2026 and about $34.0 million in Q2, against roughly $15 million a year earlier, for about $109 million over the trailing twelve months. Gross margin is about 22% on that base. Management guided in May to at least $130 million of 2026 revenue, and analysts now average about $141 million for the year and about $212 million for 2027. The investment question is whether that ramp can continue at scale and convert into durable gross margin and eventual profitability, rather than remaining a series of project and pilot wins.
Q3 2026 results on November 5.
Amprius reports third-quarter 2026 results on November 5. Consensus expects revenue of about $35.7 million and a loss of about $0.01 per share. In each of the last two reported quarters the company lost $0.04 per share against smaller expected losses, even as revenue grew, so the margin line and any update to full-year guidance are likely to draw as much attention as the top line.
The bear case: what would have to be true for $14.00
The most pessimistic published target is $14.00, +81.6% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Amprius Technologies is worth if the risks below bite instead of the drivers above.
Amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. Cash stood at about $74.5 million at the end of June 2026, and the October 2026 shelf registration gives it a ready route to issue new shares. The capital-light strategy concentrates execution risk in contract manufacturers, and revenue has historically been concentrated in a small number of customers and end markets such as drones and defense, where order timing can be lumpy. Competition is intense, from large established lithium-ion makers steadily improving their cells to other silicon-anode and next-generation battery startups. The stock is volatile and sensitive to order news, guidance changes, and shifts in defense, drone, and EV demand. Between October 2025 and October 2026 the shares traded between about $7.28 and $24.23, and they fell about 26% over the three months to October 16, 2026.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding AMPX already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on AMPX
10 analysts cover AMPX, with an average target of $22.10 (+186.6% against $7.71) and a split of 11 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the AMPX forecast and price target page.
How is AMPX valued? (as of October 2026)
Snapshot for AMPX as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$109 million
- Revenue (Q2 2026): ~$34.0 million (up ~126% year over year)
- Revenue (FY2025): ~$73.0 million (up about 3x year over year)
- Gross margin (TTM): ~22%
- Net loss (TTM): ~$38 million (Q2 2026: ~$5.1 million)
- Cash and equivalents: ~$74.5 million (end of June 2026)
- Market cap: ~$1.2 billion
- Price/sales (TTM): ~11x
Amprius is a speculative, ramp-stage company, so it cannot be valued on current earnings; the market prices it on the option value of future growth, at roughly 11 times trailing sales. Analysts expect a small loss in 2026 and about $0.10 of EPS in 2027 on revenue near $212 million, so the valuation leans on that ramp arriving on time. Cash, share count and market cap can move materially with capital raises, and the October 2026 shelf filing makes that more likely to come up.
How do you decide if AMPX is a buy?
Rather than asking whether AMPX is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold AMPX indirectly through an index or sector ETF before adding more.
What would change your mind on AMPX
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Energy-density edge stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the AMPX stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AMPX against your real portfolio and see your actual exposure before deciding.
Investing in Amprius Technologies with AI
Connect the broker you already use and ask Walnut's AI how AMPX fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is AMPX a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Energy-density edge, with revenue (ttm) at ~$109 million. The bear case rests on amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. Analysts covering it are spread from $14.00 to $30.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell AMPX?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $14.00, +81.6% from the $7.71 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for AMPX?
+
Energy-density edge. Amprius's core pitch is that silicon-anode cells store more energy per unit of weight and volume than conventional lithium-ion. The most optimistic analyst target on AMPX is $30.00, +289.1% from the $7.71 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for AMPX?
+
Amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. Cash stood at about $74.5 million at the end of June 2026, and the October 2026 shelf registration gives it a ready route to issue new shares. The capital-light strategy concentrates execution risk in contract manufacturers, and revenue has historically been concentrated in a small number of customers and end markets such as drones and defense, where order timing can be lumpy. Competition is intense, from large established lithium-ion makers steadily improving their cells to other silicon-anode and next-generation battery startups. The stock is volatile and sensitive to order news, guidance changes, and shifts in defense, drone, and EV demand. Between October 2025 and October 2026 the shares traded between about $7.28 and $24.23, and they fell about 26% over the three months to October 16, 2026. The most pessimistic published target is $14.00, +81.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Amprius Technologies do?
+
Amprius Technologies develops and sells silicon-anode lithium-ion batteries that target higher energy density than conventional graphite-anode cells, meaning more energy in the sam
What would have to change for AMPX to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Energy-density edge) stalling in the reported numbers rather than in the narrative, the risk above (amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Amprius do?
+
Amprius Technologies develops and sells silicon-anode lithium-ion batteries with higher energy density than conventional graphite-anode cells. Its SiMaxx platform uses a 100% silicon-nanowire anode made in Fremont, California, and its SiCore platform is a commercially available, scalable line. The cells target aviation, eVTOL, drones, defense, and electric vehicles, where light weight and long runtime matter most.
What is AMPX's ticker symbol and where does it trade?
+
Amprius Technologies trades under the ticker AMPX on the New York Stock Exchange. The company is headquartered in Fremont, California, and went public in 2022 through a SPAC merger. It trades during US market hours and is available at every major US brokerage, including as fractional shares at brokers that offer them.
Is AMPX profitable?
+
No. Amprius is in an early commercial ramp and has been unprofitable, reporting a net loss of about $44 million for 2025 that included a large Colorado facility impairment. The loss has narrowed in 2026 to about $5 million a quarter, with a trailing net loss of about $38 million through June. Analysts expect a small loss for 2026 and a small profit in 2027, but the company still relies on its cash balance (about $74.5 million in June 2026) and could raise additional capital.
Walnut is informational, not investment advice, and gives no verdict on AMPX. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature AMPX
AMPX is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.